Results 71 to 80 of about 8,273 (177)

Developing an On‐Resin Synthesis of α‐Galactosylceramide‐Peptide Conjugate Vaccines

open access: yesChemistryEurope
The covalent attachment of peptide antigens to the NKT cell agonist, α‐galactosylceramide (αGalCer), generates self‐adjuvanting vaccines that prevent and/or eliminate disease in animal models of cancer and infectious disease.
Dr. Michael A. Meijlink   +10 more
doaj   +1 more source

Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice

open access: yesScientific Reports, 2018
Lupus nephritis is a crucial complication of systemic lupus erythematosus. In this study, we investigated the roles of mouse natural killer T (NKT) cells in lupus nephritis.
Takahiro Uchida   +8 more
doaj   +1 more source

Modulation of NKT cells and Th1/Th2 imbalance after α-GalCer treatment in progressive load-trained rats

open access: yesInternational Journal of Biological Sciences, 2009
Purpose: The purpose of this study was to determine whether α-galactosylceramide (α-GalCer), a synthetic glycolipid agonist of natural killer T (NKT) cells, can ameliorate exercise-induced immune imbalance.
Wang Ru, Chen Peijie
doaj  

GAL3ST1-Mediated Histone Tyrosine Sulfation Induced by Cancer-Associated Fibroblasts Promotes Gastric Cancer Metastasis. [PDF]

open access: yesCancer Res
Lu Y   +17 more
europepmc   +1 more source

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells. [PDF]

open access: yesStem Cell Res Ther
Aoki T   +16 more
europepmc   +1 more source

Brain lipid profiles and oligodendrocyte gene expression show discordant responses to high-fat diet in Alzheimer's disease mice. [PDF]

open access: yesSci Rep
Kawade N   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy